EH

Ekramul Haque

Director Director DIN 06677087
DIN 06677087 First appointment Oct 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2013
Shareholding value Locked Premium profile

About Ekramul Haque

Data last updated:

Ekramul Haque has 12 years in corporate governance. Formerly with 1 company, such as Remedy Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

DIN 06677087
Primary Designation Director
First Appointment 22 Oct 2013
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Remedy Healthcare Private Limited U74999DL2013PTC259439
Director22 Oct 20132013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Remedy Healthcare Private Limited
Premium access

Shareholding and investment profile for Ekramul Haque

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ekramul Haque

Ekramul Haque has 12 years in corporate governance. Formerly with 1 company, such as Remedy Healthcare Private Limited. Engaged in Healthcare. Contributes to corporate operations.

Ekramul Haque is associated with 0 companies as a director.

Ekramul Haque has expertise in Healthcare.

Ekramul Haque has 12 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available